文献速递神经MR

多扩散指标的全肿瘤直方图分析用于胶质瘤基因分型

Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping.
PubMed 文献 · Radiology · 2021-12-07

前瞻性纳入2018年12月至2020年12月的215例胶质瘤患者,比较DTI、DKI、NODDI和MAP直方图特征预测IDH突变和1p/19q共缺失的诊断效能;各模型AUC无显著差异,DTI与先进扩散模型性能相似,多指标全肿瘤直方图分析似乎是有前景的基因分型方法。

要点

  • 全肿瘤直方图分析多扩散指标可用于预测胶质瘤IDH突变和1p/19q共缺失。
  • DTI预测IDH突变AUC为0.76,与DKI、NODDI、MAP及联合模型无显著差异。
  • IDH突变胶质瘤中预测1p/19q共缺失,DTI的AUC为0.83,与先进扩散模型无显著差异。

核心结论

  • 多扩散指标的全肿瘤直方图分析似乎是有前景的胶质瘤IDH和1p/19q基因分型方法,且DTI的性能与先进扩散模型相似。

研究设计与样本

  • 前瞻性研究,纳入2018年12月至2020年12月的215例胶质瘤患者(男115例、女100例,平均年龄48岁±13岁),包括II级68例、III级35例、IV级112例;采用自旋回波平面成像序列,b值0及500、1000、1500、2000、2500 sec/mm2,每个b值30个方向;计算DTI、DKI、NODDI和MAP扩散指标,分析全肿瘤及瘤周水肿区域的直方图特征;以IDH基因型和1p/19q共缺失状态分组比较,采用逻辑回归预测基因型。

诊断标准与关键数值

  • 预测IDH突变,DTI、DKI、NODDI、MAP及联合模型的AUC分别为0.76、0.82、0.78、0.81、0.82,各模型间P > .05;在IDH突变胶质瘤中预测1p/19q共缺失,上述模型的AUC分别为0.83、0.81、0.82、0.83、0.88,各模型间P > .05。

临床应用与阅片要点

  • 阅片和报告中可采用全肿瘤直方图分析多扩散指标辅助预测胶质瘤IDH和1p/19q状态;DTI与先进扩散模型诊断性能相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The isocitrate dehydrogenase (IDH) genotype and 1p/19q codeletion status are key molecular markers included in glioma pathologic diagnosis. Advanced diffusion models provide additional microstructural information. Purpose To compare the diagnostic performance of histogram features of multiple diffusion metrics in predicting glioma IDH and 1p/19q genotyping. Materials and Methods In this prospective study, participants were enrolled from December 2018 to December 2020. Diffusion-weighted imaging was performed by using a spin-echo echo-planar imaging sequence with five b values (500, 1000, 1500, 2000, and 2500 sec/mm2) in 30 directions for every b value and one b value of 0. Diffusion metrics of diffusion-tensor imaging (DTI), diffusion-kurtosis imaging (DKI), neurite orientation dispersion and density imaging (NODDI), and mean apparent propagator (MAP) were calculated, and their histogram features were analyzed in regions that included the entire tumor and peritumoral edema. Comparisons between groups were performed according to IDH genotype and 1p/19q codeletion status. Logistic regression analysis was used to predict the IDH and 1p/19q genotypes. Results A total of 215 participants (115 men, 100 women; mean age, 48 years ± 13 [standard deviation]) with grade II (n = 68), grade III (n = 35), and grade IV (n = 112) glioma were included. Among the DTI, DKI, NODDI, MAP, and total diffusion models, there were no significant differences in the areas under the receiver operating characteristic curve (AUCs) for predicting IDH mutations (AUC, 0.76, 0.82, 0.78, 0.81, and 0.82, respectively; P > .05) and 1p/19q codeletion in gliomas with IDH mutations (AUC, 0.83, 0.81, 0.82, 0.83, and 0.88, respectively; P > .05). A regression model with an R2 value of 0.84 was used for the Ki-67 labeling index and histogram features of the diffusion metrics. Conclusion Whole-tumor histogram analysis of multiple diffusion metrics is a promising approach for glioma isocitrate dehydrogenase and 1p/19q genotyping, and the performance of diffusion-tensor imaging is similar to that of advanced diffusion models. Clinical trial registration no. ChiCTR2100048119 © RSNA, 2021 Online supplemental material is available for this article. An earlier incorrect version appeared online. This article was corrected on December 14, 2021.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Gao, Zhang, Yan, et al. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping. Radiology. 2021. PMID: 34874198. doi:10.1148/radiol.210820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。